electroCore (NASDAQ:ECOR – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.07), FiscalAI reports. The company had revenue of $8.69 million for the quarter, compared to the consensus estimate of $7.84 million. electroCore had a negative net margin of 47.46% and a negative return on equity of 308.23%. electroCore updated its FY 2025 guidance to EPS.
electroCore Trading Up 3.1%
Shares of ECOR traded up $0.18 during trading hours on Friday, reaching $6.02. 247,092 shares of the stock traded hands, compared to its average volume of 113,027. The company has a market cap of $48.16 million, a P/E ratio of -3.52 and a beta of 0.30. The company’s 50-day moving average price is $5.02 and its two-hundred day moving average price is $5.61. electroCore has a 52-week low of $4.16 and a 52-week high of $19.49.
Insider Buying and Selling
In other electroCore news, Director Thomas J. Errico acquired 15,000 shares of the stock in a transaction dated Monday, August 11th. The shares were acquired at an average cost of $4.47 per share, for a total transaction of $67,050.00. Following the completion of the transaction, the director directly owned 281,401 shares of the company’s stock, valued at approximately $1,257,862.47. The trade was a 5.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 13.80% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on ECOR shares. Weiss Ratings reissued a “sell (e+)” rating on shares of electroCore in a report on Wednesday, October 8th. Wall Street Zen cut electroCore from a “hold” rating to a “sell” rating in a research report on Saturday, August 9th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $25.50.
Check Out Our Latest Analysis on electroCore
electroCore Company Profile
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
See Also
- Five stocks we like better than electroCore
- What is the Australian Securities Exchange (ASX)
- Dave Stock: 180% Gain + Q3 Beat = Breakout Setup?
- Earnings Per Share Calculator: How to Calculate EPS
- Cameco Stock Falls After Earnings, Why the Dip May Be a Gift
- What is the Hang Seng index?
- Amgen Stock: New All-Time Highs Ahead After Earnings Beat
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
